Oncology
Symposium
Immunotherapy: the lethal weapon against thoracic malignancies?
Clinical
Aims : To focus on the principles of immunotherapy and various clinical treatment strategies as immunotherapy will most likely change current practice in the treatment of thoracic malignancies; to highlight the most relevant clinical data regarding lung cancer and malignant pleural mesothelioma.
Target audience :
Clinician, Fellow, Immunologist, Oncologist, Pathologist, Patient, Pharmaceutical industry representative, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Scientist, Student, Thoracic endoscopist, Thoracic surgeon
08:30
Rationale and targets of immunotherapy in thoracic malignancies
A. Scherpereel(Lille Cedex, France)
COI
-
Description
1
233
09:00
Current place and future of immunotherapy in lung cancer
T. Berghmans(Bruxelles, Belgium)
COI
-
Description
2
234
09:30
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
S. Albelda(Philadelphia, United States)
COI
-
Description
3
235
10:00
How to select good candidates for immunotherapy against thoracic malignancies
S. Lantuejoul(Lyon, France)
COI
-
Description
4
236
. . .
